About Us News & Events Investors Careers
Search
Products Solutions Technologies Disease States Contact Us
Point-of-Care Manufacturing Consolidation

Providing the solutions for molecular diagnostics.

At Nanogen, Inc., we develop diagnostic products that enable physicians to deliver improved patient care. Our products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care.

Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. Our business focus is to bring better results to diagnostics and healthcare.

Latest news More
Nanogen Awarded New CDC Contract to Develop Molecular Diagnostic Test for Influenza and Avian Flu
Nanogen Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
Nanogen Announces Consolidation of Point of Care Manufacturing Operations

Upcoming Events More
Jul 27 - 31, 2008   American Associate for Clinical Chemistry (AACC)
Sep 17 - 20, 2008   Intermountain States Seminar (IMSS)
Sep 21 - 24, 2008   Heart Failure Society of America (HFSA)